These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 18946539)

  • 21. Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia.
    Kiss T; Hoffmann WE; Hajós M
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):29-42. PubMed ID: 20334724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia.
    du Bois TM; Huang XF
    Brain Res Rev; 2007 Feb; 53(2):260-70. PubMed ID: 17014910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function.
    Gupta SC; Ravikrishnan A; Liu J; Mao Z; Pavuluri R; Hillman BG; Gandhi PJ; Stairs DJ; Li M; Ugale RR; Monaghan DT; Dravid SM
    Sci Rep; 2016 Dec; 6():38321. PubMed ID: 27922130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.
    Cohen SM; Tsien RW; Goff DC; Halassa MM
    Schizophr Res; 2015 Sep; 167(1-3):98-107. PubMed ID: 25583246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oscillatory Synchronous Inhibition in the Basolateral Amygdala and its Primary Dependence on NR2A-containing NMDA Receptors.
    Aroniadou-Anderjaska V; Pidoplichko VI; Figueiredo TH; Braga MFM
    Neuroscience; 2018 Mar; 373():145-158. PubMed ID: 29339324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
    Castañé A; Santana N; Artigas F
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia.
    Gulchina Y; Xu SJ; Snyder MA; Elefant F; Gao WJ
    J Neurochem; 2017 Nov; 143(3):320-333. PubMed ID: 28628228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801.
    Lemercier CE; Holman C; Gerevich Z
    Schizophr Res; 2017 Oct; 188():118-124. PubMed ID: 28109667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin model of schizophrenia: emerging role of glutamate mechanisms.
    Aghajanian GK; Marek GJ
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):302-12. PubMed ID: 10719157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
    Beneyto M; Meador-Woodruff JH
    Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct and indirect modulation of the N-methyl D-aspartate receptor.
    Marino MJ; Conn PJ
    Curr Drug Targets CNS Neurol Disord; 2002 Feb; 1(1):1-16. PubMed ID: 12769631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
    Mueller HT; Haroutunian V; Davis KL; Meador-Woodruff JH
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):60-9. PubMed ID: 14969737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players.
    Meunier CN; Chameau P; Fossier PM
    Front Synaptic Neurosci; 2017; 9():2. PubMed ID: 28203201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics.
    MacKay MB; Paylor JW; Wong JTF; Winship IR; Baker GB; Dursun SM
    Front Psychiatry; 2018; 9():537. PubMed ID: 30425662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.
    Laruelle M; Frankle WG; Narendran R; Kegeles LS; Abi-Dargham A
    Clin Ther; 2005; 27 Suppl A():S16-24. PubMed ID: 16198197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model.
    Wesseling H; Want EJ; Guest PC; Rahmoune H; Holmes E; Bahn S
    J Proteome Res; 2015 Aug; 14(8):3174-87. PubMed ID: 26043028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are Hallucinations Due to an Imbalance Between Excitatory and Inhibitory Influences on the Brain?
    Jardri R; Hugdahl K; Hughes M; Brunelin J; Waters F; Alderson-Day B; Smailes D; Sterzer P; Corlett PR; Leptourgos P; Debbané M; Cachia A; Denève S
    Schizophr Bull; 2016 Sep; 42(5):1124-34. PubMed ID: 27261492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.
    Nakazawa K; Jeevakumar V; Nakao K
    NPJ Schizophr; 2017; 3():7. PubMed ID: 28560253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: Effects of antipsychotic drugs and receptor ligands.
    Lladó-Pelfort L; Troyano-Rodriguez E; van den Munkhof HE; Cervera-Ferri A; Jurado N; Núñez-Calvet M; Artigas F; Celada P
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):614-25. PubMed ID: 26781158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.